CICATRIN Cutaneous Powder

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Active ingredient:

NEOMYCIN SULFATE BACITRACIN ZINC CYSTEINE THREONINE AMINOACETIC ACID

Available from:

GlaxoSmithKline (Ireland) Limited

Pharmaceutical form:

Cutaneous Powder

Authorization date:

2002-04-01

Summary of Product characteristics

PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Cicatrin Cutaneous Powder.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram of powder contains:
Neomycin Sulphate
3,300 units
Bacitracin Zinc
250 units
Glycine
10 mg
L (+) Cysteine
2 mg
DL-Threonine
1 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cutaneous powder.
A cream to white free-flowing powder.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Cicatrin Powder is broad-spectrum bactericidal preparations active against pathogens commonly found in infections of
the skin. They are indicated in the prevention or treatment of superficial skin infection. These include:-
Prophylaxis in minor burns, cuts, scratches and abrasions and following the suturing of lacerations.
Treatment of superficial infected ulcers, cuts, scratches, and abrasions, superficial skin infections following surgical
procedures, minor burns, impetigo and secondarily infected skin conditions.
The use of Cicatrin Powder does not exclude concomitant systemic therapy with other antibiotics where appropriate.
(See _Special Warnings and Special Precautions for Use_).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
(Prophylaxis and treatment).
_Administration and dosage in adults:_
Before use, the area for application should be cleaned gently. Debris such as pus or crusts should be removed from the
affected area.
A light dusting of powder should be applied once to four times daily, depending on the clinical condition. Treatment
should not be continued for more than 7 days without medical supervision (see _Special Warnings and Special_
_Precautions for Use_).
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 29/10/2008_
_CRN 2057731_
_page number: 1_